£85.50

Springer Gene Therapy for Acute and Acquired Diseases

Price data last checked 55 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 36 days • 36 data points (No recent data available)

Historical
Generating forecast...
£87.71 £85.18 £85.73 £86.28 £86.84 £87.39 £87.94 25 January 2026 02 February 2026 11 February 2026 20 February 2026 01 March 2026

Price Distribution

Price distribution over 36 days • 2 price levels

Days at Price
Current Price
31 days · current 5 days 0 8 16 23 31 £85 £88 Days at Price

Price Analysis

Most common price: £85 (31 days, 86.1%)

Price range: £85 - £88

Price levels: 2 different prices over 36 days

Description

In recent years much enthusiasm and energy has been directed toward the development of human gene therapies, especially for inherited conditions and cancers. However, current gene transfer technology is limited in its transduction efficiency and ability to permanently and safely correct genomic defects. Thus the promise of gene therapy for these conditions is as yet unrealized. The progression of gene transfer technology will eventually surmount these limitations. Gene Therapy for Acute and Acquired Diseases includes selected examples of ongoing studies in molecular genetics that have the potential to evolve into human therapies for acute illnesses. These chapters are intended to highlight lesser known applications of gene therapy for acquired disorders. It is expected that human gene therapy trials for these conditions will be forthcoming in the near future, leading to previously unimaginable therapies. Thus, this first-ever book about gene therapy for acute and acquired diseases is intended to serve as a glimpse into the future.

Product Specifications

Barcode

No barcode data available